Rahman Md Mizanur, Nakamura Ryota, Islam Md Monirul, Alam Md Ashraful, Azmat Syed Khurram, Sato Motohiro
Research Center for Health Policy and Economics, Hitotsubashi University, Tokyo 186-8601, Japan.
Graduate School of Economics, Hitotsubashi University, Tokyo 186-8601, Japan.
Healthcare (Basel). 2024 Jul 15;12(14):1402. doi: 10.3390/healthcare12141402.
The aim of this multi-country, cluster-randomized trial is to test the impact of pharmacy-based health promotion to reduce the blood pressure of individuals with hypertension over a 12-month period in Bangladesh and Pakistan. The trial will be implemented with two arms. In Bangladesh, the estimated sample size is around 3600 hypertensive patients. In Pakistan, we will select samples equivalent to 10% of the participants from Bangladesh, comprising 360 hypertensive patients from four pharmacies. Community pharmacies will be randomized into one of two parallel groups (allocation ratio 1:1). Pharmacy professionals in the treatment arm will provide their patients with educational training and counseling, as well as phone calls/mobile text messages and care coordination in the health sector, as part of the intervention. The study will be conducted in three phases: a baseline survey with intervention, a midline survey with intervention and follow-up, and an endline survey with impact evaluation. The primary outcome of the study will be BP. The secondary outcomes will be BP controlled to target, treatment adherence, quality of life, mortality or hospital admission rates resulting from hypertension and its related complications, incremental cost per health-related quality of life gained, knowledge on healthy lifestyle and dietary behavior, and change in the prevalence of current smoking status.
这项多国整群随机试验的目的是,在12个月的时间里,测试在孟加拉国和巴基斯坦基于药房的健康促进措施对降低高血压患者血压的影响。该试验将分为两组进行。在孟加拉国,估计样本量约为3600名高血压患者。在巴基斯坦,我们将选取相当于孟加拉国参与者10%的样本,包括来自四家药房的360名高血压患者。社区药房将被随机分为两个平行组之一(分配比例为1:1)。作为干预措施的一部分,治疗组的药房专业人员将为患者提供教育培训和咨询,以及在卫生部门的电话/手机短信和护理协调服务。该研究将分三个阶段进行:干预前基线调查、干预及随访中期调查以及影响评估的终期调查。该研究的主要结果将是血压。次要结果将是血压控制达标情况、治疗依从性、生活质量、高血压及其相关并发症导致的死亡率或住院率、每获得一个与健康相关的生活质量所增加的成本、对健康生活方式和饮食行为的了解,以及当前吸烟状况患病率的变化。